Le Lézard
Classified in: Health
Subjects: LBR, AVO, CPG

Understaffing at Long-Term Care Facilities has Become "Epidemic" Across Ontario


RICHMOND HILL, ON, Feb. 1, 2019 /CNW/ -

Canada's Healthcare Union (CNW Group/SEIU Healthcare)

Statement from SEIU Healthcare President Sharleen Stewart:

"As the union that represents the most long-term care workers in Ontario, the understaffing and health and safety issues highlighted by today's CBC Marketplace story are unfortunately all-too-familiar to us. We have been speaking out and ringing alarm bells on these issues for over a decade. Understaffing has now become an epidemic in LTC facilities across the province and we continue to demand immediate solutions to this crisis. We are urging the Ontario government to work with us and the more than 24,000 frontline LTC staff we represent to establish a mandatory minimum hours of direct care for residents and additional funding to allow long-term care facilities to be staffed sufficiently. Until these changes happen, the health and safety of residents and staff in long-term care facilities will continue to be at serious risk."

ABOUT SEIU HEALTHCARE
SEIU Healthcare represents more than 60,000 healthcare and community service workers across Ontario. The union's members work in hospitals, homecare, nursing and retirement homes, and community services throughout the province. SEIU Healthcare has a strong track record of improving wages, benefits, and working conditions for healthcare workers, supporting the training and development needs of its members, and strengthening standards in the management and delivery of patient and client care. www.seiuhealthcare.ca.

SOURCE SEIU Healthcare


These press releases may also interest you

at 08:07
On the evening of May 5, Kexing Biopharm (stock code: 688136) announced it had obtained a "Certificate of GMP Compliance of a Manufacturer" granted by the Norwegian Medical Products Agency in accordance with the European Medicines Agency (EMA)...

at 08:05
Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024, at 3:35 pm ET. The presentation will...

at 08:05
Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced preclinical data from the Company's platform and pipeline. The data are being presented on Friday, May 10,...

at 08:05
Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will participate in the following upcoming...

at 08:05
$16.3 million in cash and cash equivalents at the end of Q1 2024 providing projected cash runway into Q1 2026 Third amendment made in Q1 to Cipla partnership results in the wind down of the PUR1900 Phase 2b study and allows for a significant...

at 08:01
Intensity Therapeutics, Inc. ("Intensity" or "the Company") , a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase...



News published on and distributed by: